Angiosarcoma Treatment Market - Regional Analysis
North America Market Insights
The North America industry is poised to dominate majority revenue share of 35% by 2035. This is due to the development of medical infrastructure and government policies that favor the research and development of new drugs and treatments. According to the National Cancer Institute, the cancer research budget increased by 99.3 million (1.6%) from 2020 to 2021. Additionally, cases of angiosarcomas as well as lymphedema and syncope are increasing. increased in this area. In the United States, one case of angiosarcoma is diagnosed each year in every million people. About 1 to 2% of all sarcomas are angiosarcomas.
APAC Market Insights
The angiosarcoma treatment market in Asia Pacific region is expected to grow substantially during the forecast period. The growth of this market can be ascribed on the back of an increasing number of old age population found in this region. Due to weakening body functions and less immunity the old population in the region majorly suffers from cancer as compared to the middle or young adults which is predicted to raise the market growth of the angiosarcoma treatment market in the projected time period.
